CAS 405-85-6
:4-[(3-fluorobenzyl)oxy]benzoic acid
Description:
4-[(3-Fluorobenzyl)oxy]benzoic acid, with the CAS number 405-85-6, is an organic compound characterized by its aromatic structure and functional groups. It features a benzoic acid moiety, which includes a carboxylic acid (-COOH) group, contributing to its acidic properties. The presence of a 3-fluorobenzyl ether substituent enhances its chemical reactivity and solubility in organic solvents. This compound typically appears as a white to off-white solid and is soluble in polar organic solvents. Its fluorine atom can influence the compound's electronic properties, potentially affecting its interactions in biological systems or its utility in various chemical applications. The compound may be used in pharmaceutical research, particularly in the development of drugs or as an intermediate in organic synthesis. Safety data sheets should be consulted for handling and storage guidelines, as with any chemical substance, to ensure safe laboratory practices.
Formula:C14H11FO3
InChI:InChI=1/C14H11FO3/c15-12-3-1-2-10(8-12)9-18-13-6-4-11(5-7-13)14(16)17/h1-8H,9H2,(H,16,17)
SMILES:c1cc(cc(c1)F)COc1ccc(cc1)C(=O)O
Synonyms:- Benzoic Acid, 4-[(3-Fluorophenyl)Methoxy]-
- 4-[(3-Fluorobenzyl)oxy]benzoic acid
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
Safinamide Impurity 10
CAS:Formula:C14H11FO3Color and Shape:White To Off-White SolidMolecular weight:246.244-(3-Fluorobenzyloxy)benzoic acid
CAS:4-(3-Fluorobenzyloxy)benzoic acidFormula:C14H11FO3Purity:≥95%Color and Shape:SolidMolecular weight:246.233744-[(3-Fluorobenzyl)oxy]benzoic Acid
CAS:Controlled ProductApplications 4-[(3-Fluorobenzyl)oxy]benzoic acid is a metabolite of Safinamide. Safinamide is a potent and selective MAO-B inhibitor, and is used as an add-on treatment to treat Parkinson’s disease.
References Finberg, J.P.M., et al.: Front Pharmacol., 7, 340-54 (2016);Formula:C14H11FO3Color and Shape:NeatMolecular weight:246.234NW-1689
CAS:NW-1689 is a process-related impurity of safinamide mesilate (SAFM), which is a medication used in the treatment of Parkinson's disease (PD). SAFM acts as a highly selective and reversible inhibitor of monoamine oxidase-B (MAO-B) and also blocks sodium and N-type calcium channels. These actions assist in reducing dopamine breakdown and suppressing glutamate release. NW-1689 shares structural similarities with SAFM and exhibits comparable pharmacological effects, making it applicable in Parkinson's disease research.Formula:C14H11FO3Color and Shape:SolidMolecular weight:246.23Ref: IN-DA0076HD
Discontinued product







